Visual field testing: timing and analysis in patients with POAG

Article

The periodic assessment of vision function with visual field testing is a standard and important part of the management of primary open-angle glaucoma (POAG). Automated achromatic static threshold perimetry is the preferred technique, although other static and kinetic techniques are acceptable alternatives in patients who are unable to complete automated perimetry reliably or when the technology is not available.

The periodic assessment of vision function with visual field testing is a standard and important part of the management of primary open-angle glaucoma (POAG).1 Automated achromatic static threshold perimetry is the preferred technique,2-5 although other static and kinetic techniques are acceptable alternatives in patients who are unable to complete automated perimetry reliably or when the technology is not available.1

Determining an optimal interval between visual field testing in an individual patient with POAG can be challenging. Like most things in glaucoma, care must be individualized. In addition to considering clinical characteristics and patient risk factors in scheduling follow-up examinations, the physician must consider the data set required for using statistical tools to analyze visual field changes over time. This article explores clinical features and risk factors that should be considered in scheduling follow-up visits for visual field testing and the two primary analytical strategies-event analysis and trend analysis-in current use for quantifying visual field changes.

Recommended follow-up intervals

As shown in the table, the recommended follow-up interval varies from 1 to 12 months-a relatively wide range-depending on patient characteristics. A follow-up interval as short as 1 month may be indicated for patients who are just learning to take fields and whose tests are unreliable, for those in whom progression is suspected, to confirm progression, or for those in whom target IOP is not achieved. With new visual field software, it may be advisable to obtain a few fields in the first several months to establish a solid baseline. Other clinical settings also may require a short follow-up interval. No patients have a recommended follow-up interval longer than 12 months; thus, visual field and optic nerve head evaluation should be done at least annually under the best of circumstances. Of course, visual field testing may not provide for far advanced glaucoma when the field is nearly extinguished.1

In addition to automated achromatic threshold perimetry (AAP), several other visual field testing technologies are available. Visual field testing based on short-wavelength automated perimetry (SWAP) and frequency-doubling technology (FDT) may detect defects earlier than conventional white-on-white perimetry.6 To generate a useful measure of progression in an individual patient, the physician should employ a consistent testing strategy over time. It is not established whether SWAP or FDT will provide additional information about progression once AAP has demonstrated a glaucomatous defect.

The following factors should be considered when determining an appropriate follow-up interval for visual field testing and optic nerve evaluation1 :

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.